Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[50 years lithium treatment].

M Schou1

  • 1Hôpital Psychiatrique, Risskov, Danemark.

L'Encephale
|June 20, 2000
PubMed
Summary
This summary is machine-generated.

Lithium demonstrates prophylactic action in bipolar disorder, significantly reducing suicidal behavior and mortality. New mood stabilizers lack comparable evidence, highlighting lithium

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Return to work after COVID-19 infection - A Danish nationwide registry study.

Public health·2022
Same author

Increased long-term risk of heart failure and other adverse cardiac outcomes in dermatomyositis and polymyositis: Insights from a nationwide cohort.

Journal of internal medicine·2021
Same author

Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic.

International journal of cardiology. Heart & vasculature·2020
Same author

Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study.

Journal of internal medicine·2020
Same author

Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes.

Diabetes & metabolism·2018
Same author

Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.

Psychological medicine·2016
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Area of Science:

  • Psychopharmacology
  • Mood Stabilizer Research
  • Bipolar Disorder Treatment

Context:

  • Lithium's established role in bipolar disorder treatment is questioned by emerging mood stabilizers.
  • Concerns exist regarding the demonstration of lithium's prophylactic efficacy and long-term effects.
  • The comparative effectiveness of lithium versus newer anticonvulsants (carbamazepine, valproate) requires rigorous evaluation.

Purpose:

  • To critically assess the prophylactic action of lithium in bipolar disorder.
  • To evaluate the impact of long-term lithium treatment on suicidal behavior and mortality.
  • To compare the risk-benefit profiles of lithium with newer mood stabilizers, particularly during pregnancy and lactation.

Summary:

  • Evidence supports lithium's prophylactic action and its association with reduced suicidal behavior and mortality, outperforming other mood stabilizers.

Related Experiment Videos

  • Newer anticonvulsants like carbamazepine and valproate show weak or missing evidence for prophylactic use in typical bipolar disorder.
  • Future trials must be designed to rigorously compare new drugs against lithium, considering efficacy, safety, and long-term outcomes.

    • Impact:

    • This analysis underscores the continued importance of lithium as a first-line prophylactic agent for bipolar disorder.
    • It highlights the need for well-designed comparative trials to guide the selection of optimal mood stabilizers.
    • Ensuring patients receive the most effective prophylactic treatment, potentially lithium, is critical for managing bipolar disorder and preventing mortality.